Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...
As someone who has a been a licensed pharmacist and business owner for nearly four decades, Rep. Diana Harshbarger (R-TN) has a unique perspective on rising drug prices. Like many members of ...
Starting Jan. 1, 2025, millions of Americans who get their prescription drugs through Medicare could get a major financial break when a $2,000 out-of-pocket spending cap on medications goes into ...